Brian Latimer
Impact in
- Emergency Medicine top 10%
- Poisoning and overdose treatments
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Natural product bioactivities and synthesis 3
- Heme Oxygenase-1 and Carbon Monoxide 3
-
- Poisoning and overdose treatments 7
- Co-authors
- Kenneth E. McMartin (10 shared papers)Tammy R. Dugas (3 shared papers)Fleurette Abreo (3 shared papers)Paul Thevenot (1 shared paper)Valeria Y. Hebert (1 shared paper)Barry Dellinger (1 shared paper)Farhana Hasan (1 shared paper)Stephania A. Cormier (1 shared paper)
- Journals
- Clinical Toxicology (5 papers)Cancer (1 paper)Microbial Cell (1 paper)Nature Communications (1 paper)Neurobiology of Aging (1 paper)
- Partner nations
- United StatesNorwayGermany
In The Last Decade
Brian Latimer
20 papers receiving 311 citations
Peers
Comparison fields: 5 of 91
- Emergency Medicine 67
- Pharmacology 52
- Aging 10
- Molecular Medicine 27
- Health, Toxicology and Mutagenesis 54
Countries citing papers authored by Brian Latimer
This map shows the geographic impact of Brian Latimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Latimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Latimer more than expected).
Fields of papers citing papers by Brian Latimer
This network shows the impact of papers produced by Brian Latimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Latimer. The network helps show where Brian Latimer may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Latimer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 82 | |
| 2 | 2011 | 41 | |
| 3 | 2017 | 29 | |
| 4 | 2015 | 21 | |
| 5 | Enhanced Systemic Bioavailability of Curcumin Through Transmucosal Administration of a Novel Microgranular Formulation. | 2015 | 20 |
| 6 | 2017 | 18 | |
| 7 | 2014 | 17 | |
| 8 | 2018 | 16 | |
| 9 | 2019 | 12 | |
| 10 | 2017 | 11 | |
| 11 | 2020 | 11 | |
| 12 | 2021 | 8 | |
| 13 | 2023 | 7 | |
| 14 | 2021 | 5 | |
| 15 | 2024 | 4 | |
| 16 | 2021 | 4 | |
| 17 | 2012 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2024 | 2 | |
| 20 | 2015 | 1 |
About Brian Latimer
Brian Latimer is a scholar working on Molecular Biology, Emergency Medicine, Neurology, Pharmacology and Endocrinology, having authored 20 papers that have together received 315 indexed citations. Recurring topics across this work include Poisoning and overdose treatments (7 papers), Pesticide Exposure and Toxicity (4 papers), Legionella and Acanthamoeba research (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Natural product bioactivities and synthesis (3 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers), Curcumin's Biomedical Applications (3 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). The work is most often cited by research in Emergency Medicine (67 citations), Pharmacology (52 citations), Aging (10 citations), Molecular Medicine (27 citations) and Health, Toxicology and Mutagenesis (54 citations). Brian Latimer has collaborated with scholars based in United States, Norway and Germany. Frequent co-authors include Kenneth E. McMartin, Tammy R. Dugas, Fleurette Abreo, Paul Thevenot, Valeria Y. Hebert, Barry Dellinger, Farhana Hasan, Stephania A. Cormier, M Kelley and Kurt J. Varner. Their work appears in journals such as Clinical Toxicology, Cancer, Microbial Cell, Nature Communications and Neurobiology of Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.